Drugs / Fluvastatine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02115074 | Jun 2014 → Nov 2018 | glioma | Centre Oscar Lambret | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluvastatine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02115074 ↗ |
| Route | Oral | “Per os from D1 to D14 of each 28 day cycle” NCT02115074 ↗ |